Family facts
IDVParent PIIDSPE2DB22D9239
Also listed asSPE2DB-22-D-9239
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Period endOct 21, 2025
IDV obligated$29.1M
Child awards168
Places of performance
StatesIL
Distinctive task orders
12SPE2DB25FDM50 — 4569633649!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $2.9M · PoP Oct 21, 2025
SPE2DB25FDM44 — 4569633646!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $989K · PoP Oct 21, 2025
SPE2DB25FDM49 — 4569633648!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $742K · PoP Oct 21, 2025
SPE2DB25FDM40 — 4569633623!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $445K · PoP Oct 21, 2025
SPE2DB25FDM42 — 4569633624!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $409K · PoP Oct 21, 2025
SPE2DB24FDM57 — 4565856789!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $296K · PoP Oct 7, 2024
SPE2DB25FDG81 — 4567729092!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $294K · PoP Mar 18, 2025
SPE2DB25FDM37 — 4569659929!XTANDI 40 MG CAPSULE 120S
Dms Pharmaceutical Group Inc. · $267K · PoP Sep 29, 2025
SPE2DB25FDM38 — 4569983556!XENPOZYME 20 MG VIALS
Dms Pharmaceutical Group Inc. · $254K · PoP Oct 20, 2025
SPE2DB25FDF63 — 4566879101!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $237K · PoP Jan 27, 2025
SPE2DB24FDL14 — 4565230978!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $237K · PoP Aug 9, 2024
SPE2DB24FDG13 — 4563491331!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $237K · PoP Feb 15, 2024
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly